Tacrograf Capsules, Composition : Tacrolimus For Immunosuppressant

Tacrograf 0.5 mg is a pharmaceutical product known for its active ingredient Tacrolimus, which belongs to the class of drugs called immunosuppressants. This medication is used primarily to prevent organ rejection in patients who have undergone organ transplantation, such as kidney, liver, or heart transplant recipients. By suppressing the body's immune response, Tacrograf helps ensure the transplanted organ is not attacked and rejected by the immune system.
Mechanism of Action: The active ingredient Tacrolimus in Tacrograf works by inhibiting the activity of certain immune cells called T-lymphocytes (T-cells). T-cells play a crucial role in the immune system's defense mechanisms and are responsible for identifying and attacking foreign substances, including transplanted organs. By blocking the T-cells' activation, Tacrograf reduces the immune system's response, preventing it from targeting and damaging the transplanted organ.
Dosage and Administration: Tacrograf 0.5 mg is available in oral form, usually in the form of capsules. The dosage may vary depending on individual patient factors, such as the type of organ transplanted, the patient's weight, medical history, and response to treatment. It is essential to follow the prescribed dosage and administration instructions provided by the transplant specialist or healthcare professional carefully. Deviating from the recommended dose may lead to complications or reduce the effectiveness of the treatment.